Dr. Jaspreet Dhillon is a research investigator with the Sutter Institute for Medical Research.
Sutter Health Research Enterprise
8 Medical Plaza
Suite 300
Roseville, CA, 95661
(916) 782-5106
DhillJK@sutterhealth.org
Primary Research Interests
Related Clinical Trials
Metastatic (AstraZeneca D533AC00001 MONETTE)
AstraZeneca D533AC00001 MONETTE: A Randomised, Open-Label, Phase 2 Study of Ceralasertib Monotherapy and Ceralasertib plus Durvalumab in Patients with Unresect
Investigators: Kristin N. Arreola M.D., Deepti Behl MD, Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Jaspreet K Dhillon Medical Oncologist, Dron Gauchan MD, Brian K. Kim M.D, Sivakumar Reddy M.D., Vijay Suhag M.D.
Status: Active, Not Recruiting
Research Studies
Adjuvant (Guardant Health 02-MX-003 ORACLE)
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (ORACLE)
Investigators: Kristin N. Arreola M.D., Deepti Behl MD, Kristie A. Bobolis M.D., Rajeswari Chellappah M.D., Jaspreet K Dhillon Medical Oncologist, Brian K. Kim M.D, Sivakumar Reddy M.D., Vijay Suhag M.D.